Tesla’s stock began rising from the opening Tuesday after Trump posted overnight on his Truth Social platform that Musk was “putting it on the line” to help the country. Trump claimed in the post that ...
Wedbush became the latest brokerage to downgrade Arvinas (NASDAQ:ARVN) on Wednesday after the company posted underwhelming ...
Wedbush analyst Laura Chico maintained a Buy rating on Astria Therapeutics (ATXS – Research Report) today and set a price target of $28.00. The ...
As previously reported, Wedbush analyst Robert Driscoll downgraded Arvinas (ARVN) to Neutral from Outperform with a price target of $12, down ...
Elon Musk’s role in the Trump administration is complicating his business ventures, as the tech billionaire pushes forward with efforts to slash the federal government and budget in the face of ...
StockNews.com upgraded shares of Willdan Group (NASDAQ:WLDN – Free Report) from a buy rating to a strong-buy rating in a research note released on Tuesday. Separately, Wedbush raised shares of Willdan ...
Immunome (NASDAQ:IMNM – Get Free Report)‘s stock had its “outperform” rating reiterated by analysts at Wedbush in a research ...
AMC is also in a good position for continued growth, Hickey wrote in a note earlier this month. Benchmark has a hold rating for the movie-theater chain and original meme stock. In a separate note, the ...
Shares of Tesla slid again Monday as confidence in Elon Musk’s electric car company continues to disintegrate following a ...
Musk has become the face of the Trump administration’s slash-and-burn government downsizing efforts, known as the Department ...
Just days after saying Tesla Inc.’s recent stock selloff was overdone, Wedbush analyst Dan Ives, a well-known tech analyst ...
Markets are still under a great deal of pressure. All thanks to more tariffs on Canada, Mexico, China and inflation threats, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results